Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) have been given an average recommendation of “Buy” by the eight ratings firms that are covering the stock, Marketbeat reports. Five research analysts have rated the stock with a buy rating. The average 12-month price target among brokerages that have issued ratings on the stock in the […]
888 reiterated their reiterates rating on shares of Vaxcyte (NASDAQ:PCVX – Get Rating) in a report published on Tuesday morning, Benzinga reports. Other equities research analysts also recently issued reports about the stock. Needham & Company LLC reissued a buy rating and set a $58.00 price target on shares of Vaxcyte in a research note […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) – Equities researchers at Cantor Fitzgerald boosted their FY2023 EPS estimates for shares of Vaxcyte in a report issued on Tuesday, May 9th. Cantor Fitzgerald analyst L. Chen now expects that the company will earn ($3.15) per share for the year, up from their prior estimate of ($3.93). The […]
Presenter SpeechJason Gerberry Thank you so much for joining us at the Bank of America Annual Healthcare Conference. My name is Jason Gerberry, I m one of the biotech analysts here. I m pleased to be. | May 10, 2023
Vaxcyte (NASDAQ:PCVX – Get Rating)‘s stock had its “reiterates” rating restated by analysts at 888 in a report issued on Tuesday, Benzinga reports. A number of other equities research analysts have also issued reports on PCVX. Bank of America upped their target price on Vaxcyte from $63.00 to $68.00 in a research note on Monday, […]